In this study, EGFR mutations were predicted using a deep learning and radiomics combined technique in which contrast-enhanced CT images and clinical data of NSCLC patients obtained before treatment were provided as input to the deep learning model. This evidence concerns the gene EGFR and non-small cell lung carcinoma.